Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Integrative analysis of prognostic long non-coding RNAs with copy number variation in bladder cancer

1 Jul 2021

Abstract excerpt

Copy number variations (CNVs), which can affect the role of long non-coding RNAs (lncRNAs), are important genetic changes seen in some malignant tumors. We analyzed lncRNAs with CNV to explore the relationship between lncRNAs and prognosis in bladder cancer (BLCA). Messenger RNA (mRNA) expression levels, DNA methylation, and DNA copy number data of 408 BLCA patients were subjected to integrative bioinformatics...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related molecular mechanisms research
Share to Ferroptosis and cancer prognosis
Share to RNA modifications and cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34414701
DOI: 10.1631/jzus.b2000494

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Integrative analysis of prognostic long non-coding RNAs with copy number variation in bladder cancerPMID 34414701Read ↗

Copy number variations primed lncRNAs deregulation contribute to poor prognosis in colorectal cancerSemantic proximity Read ↗

Bioinformatic identification of prognostic signature defined by copy number alteration and expression of CCNE1 in non-muscle invasive bladder cancerSemantic proximity Read ↗

Multi-Omics analysis identifies a lncRNA-related prognostic signature to predict bladder cancer recurrence.Semantic proximity Read ↗

Copy number variation analysis of m6 A regulators identified METTL3 as a prognostic and immune-related biomarker in bladder cancer.Semantic proximity Read ↗

Eight-lncRNA signature of cervical cancer were identified by integrating DNA methylation, copy number variation and transcriptome dataSemantic proximity Read ↗

Copy Number Variations of CEP63, FOSL2 and PAQR6 Serve as Novel Signatures for the Prognosis of Bladder CancerSemantic proximity Read ↗

The Analysis of lncRNA-miRNA-mRNA Competitive Endogenous RNA Network to Identify 4-lncRNA Signature Related to the Prognosis of Bladder CancerSemantic proximity Read ↗

Characterization of mRNA Expression and Endogenous RNA Profiles in Bladder Cancer Based on The Cancer Genome Atlas (TCGA) DatabaseSemantic proximity Read ↗

Prediction of bladder cancer outcome by identifying and validating a mutation-derived genomic instability-associated long noncoding RNA (lncRNA) signature.Semantic proximity Read ↗

Integrated Analysis of lncRNA-associated ceRNA Network Identifies Prognostic lncRNAs in Bladder Cancer Based on Whole Transcriptome Sequencing and TCGA DatabaseSemantic proximity Read ↗

Identification of epigenetic interactions between miRNA and DNA methylation associated with gene expression as potential prognostic markers in bladder cancerSemantic proximity Read ↗

Clinical impact of copy number variation changes in bladder cancer samplesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.